Bedifos review

Bedifos, originally approved by the FDA in 1961 with a foam-style formulation approved in 1999. This medication in the steroid family and comes in topical solutions available in foam, ointment, cream, lotion, or aerosol spray. This medications main function is to reduce swelling and decrease the body's immune response. This immune response is often what causes painful reactions that result in various diseases or disorders. This medication is available under several different brand names, including Beta-Val, Betalene, Betratrex, Diprolene, Diprosone, Maxivate, Valisone, Luxiq Foam, and Valnac Topical.

Bedifos is used primarily to treat hormonal or endocrine disorders. Typically with these disorders, the body does not produce its own steroids in sufficient quantity to maintain health. This can result in immune and allergic disorders and diseases such as arthritis, lupus, psoriasis, asthma, ulcerative colitis, and regional enteritis. The foam form can also be used for chronic itching and redness, dryness, crusting and scaling, eczema, and inflammation. All of these external symptoms are the body's immune reaction to irritations, causing the areas become red, swollen, and itchy, which can be extremely painful for the patient. Bedifos is able to get inside the skin cells and decrease the inflammatory response, reducing the appearance of the reactions on the skin.

As with all medications, Bedifos needs to be taken exactly as prescribed. Steroids are very sensitive to dosage levels and time of prescription. The amount and frequency may be altered by your doctor over the duration of the prescription. If you don't understand the directions, have the doctor, nurse, or pharmacist explain the directions to you. Every dose should be taken with a full glass of water and food or milk to avoid getting an upset stomach. If you are only taking one dose a day, take it before nine in the morning. If you take more than one dose, make very sure to spread them out according to the doctor's instructions. Steroid medications should never be abruptly stopped, and usually include a gradual reduction in dosage and frequency.

Patients with a history of kidney disease, liver disease, high blood pressure, or heart disease, should make sure their doctor is aware of these conditions before they start taking Bedifos. Other serious conditions such as ulcerative colitis, stomach ulcers, myasthenia gravis, hypothyroidism, diabetes mellitus, or psychiatric disorder should also be discussed with your doctor and carefully considered before beginning a course of treatment with Bedifos. Since Bedifos's function is to weaken the body's immune system, people with serious bacterial, viral, or fungal infections should not take this medication.

Patients should consume alcohol cautiously, since alcohol and Bedifos can react negatively and damage the stomach. They should also avoid infections since their body's immune system will be lowered and they will be more susceptible than usual.

Side effects of Bedifos can be very serious. An allergic reaction, which might include difficulty breathing or swelling of the throat, lips, tongue or face, or hives is possible. Side effects could also include increased blood pressure or sudden weight gain. Consult your doctor immediately if you experience any of the above side effects.

Less serious side effects could include sleeplessness, upset stomach, fatigue, dizziness, or increased hunger or thirst. Consult your doctor if you experience any of these symptoms.

If you use too much Bedifos, call your local poison control center, and your doctor immediately. If a patient loses consciousness or stops breathing call 911 immediately. Other minor symptoms of an overdose might include acne, bruising, increased hair growth, high blood pressure, swollen hands, feet or ankles, and sore or weak muscles. Seek immediate medical attention if you experience any of these symptoms.

Bedifos is classified in pregnancy category C, which means that its effects on a pregnant woman or unborn fetus are unknown. It is known that Bedifos does pass into breast milk, so a nursing mother should consult a doctor if she intends to continue breastfeeding her baby.

Bedifos has the following structural formula:

Chemical structure of bedifos

• Molecular formula of bedifos is C22H29FO5
• Chemical IUPAC Name is 9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,10,11, 12,13,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
• Molecular weight is 392.461 g/mol
Bedifos available : 0.05% cream 15gm tube, 0.05% cream 45gm tube, 0.05% lotion 60ml bottle, 0.05% ointment 15gm tube, 0.05% ointment 45gm tube, 0.1% ointment 15gm tube, 0.1% ointment 45gm tube

Generic name: Betamethasone

Brand name(s): Alphatrex, Bebate, Becort, Betacorlan, Betacortril, Betaderm, Betadexamethasone, Betafluorene, Betamamallet, Betametasona, Betametasone, Betamethasonum, Betamethazone, Betapredol, Betasolon, Betatrex, Betnelan, Betsolan, Celestene, Celestone, Cidoten, Dermabet, Desacort-Beta, Diproderm, Diprolene, Diprosone, Flubenisolone, Hormezon, Lotrisone, Luxiq, Luxiqo, Maxivate, Methazon

  Your Bedifos review